From: Can MiR-503 be used as a marker in diabetic patients with ischemic stroke?
 | N | Age (mean ± SD) | Sex (F/M) | FBS | HbA1C | TG | Chol |
---|---|---|---|---|---|---|---|
Group (I) | 15 | 64.4 ± 12.6 | 10/5 | 194 ± 54 | 7.43 ± 0.9 | 186 ± 108 | 196 ± 51 |
Group (II) | 18 | 71.4 ± 10 | 10/8 | 97 ± 16 | – | 126 ± 58 | 144 ± 25 |
Group (III) | 12 | 65.5 ± 16 | 7/5 | 162 ± 11 | 7.2 ± 0.8 | 157 ± 29 | 184 ± 45 |
Control (IV) | 5 | 68.2 ± 6 | 3/2 | 90 ± 9 | – | 118 ± 25 | 154 ± 20 |